William P. Sheridan
2019
In 2019, William P. Sheridan earned a total compensation of $1.1M as Senior Vice President and Chief Medical Officer at BioCryst Pharmaceuticals, a 55% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $170,048 |
|---|---|
| Option Awards | $382,994 |
| Salary | $500,142 |
| Other | $14,000 |
| Total | $1,067,183 |
Sheridan received $500.1K in salary, accounting for 47% of the total pay in 2019.
Sheridan also received $170K in non-equity incentive plan, $383K in option awards and $14K in other compensation.
Rankings
In 2019, William P. Sheridan's compensation ranked 8,994th out of 13,971 executives tracked by ExecPay. In other words, Sheridan earned more than 35.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,994 out of 13,971 | 36th |
Division Manufacturing | 3,607 out of 5,701 | 37th |
Major group Chemicals And Allied Products | 1,361 out of 2,200 | 38th |
Industry group Drugs | 1,160 out of 1,886 | 39th |
Industry Biological Products, Except Diagnostic Substances | 263 out of 389 | 32nd |
Source: SEC filing on March 31, 2020.
Sheridan's colleagues
We found four more compensation records of executives who worked with William P. Sheridan at BioCryst Pharmaceuticals in 2019.
2019
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
2019
Megan Sniecinski
BioCryst Pharmaceuticals
Senior Vice President and Chief Business Officer
2019
Yarlagadda Babu
BioCryst Pharmaceuticals
Senior Vice President of Drug Discovery
2019
Thomas Staab
BioCryst Pharmaceuticals